These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38164222)

  • 1. The future of myelodysplastic syndrome-patient priorities and outcomes that matter.
    Poynton M; Gilmour-Hamilton C; Dale-Harris I; Clarke E; Stanworth S; Murphy M; Roy N
    Front Med (Lausanne); 2023; 10():1267139. PubMed ID: 38164222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDS-Related Anemia Is Associated with Impaired Quality of Life but Improvement Is Not Always Achieved by Increased Hemoglobin Level.
    Haring Y; Goldschmidt N; Taha S; Stemer G; Filanovsky K; Hellman I; Okasha D; Krayem B; Levi I; Rosenbaum H; Koren-Michowitz M; Yagna S; Nemets A; Gino-Moor S; Saban R; Cohen J; Halperin E; Wolach O; Dally N; Merkel D; Oster HS; Mittelman M;
    J Clin Med; 2023 Sep; 12(18):. PubMed ID: 37762806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life, physical function and MRI T2* in elderly low-risk MDS patients treated to a haemoglobin level of ≥120 g/L with darbepoetin alfa ± filgrastim or erythrocyte transfusions.
    Nilsson-Ehle H; Birgegård G; Samuelsson J; Antunovic P; Astermark J; Garelius H; Engström LM; Kjeldsen L; Nilsson L; Olsson A; Skov-Holm M; Wallvik J; Gulbrandsen N; Hellström-Lindberg E
    Eur J Haematol; 2011 Sep; 87(3):244-52. PubMed ID: 21623919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient and physician perceptions about blood transfusions in the myelodysplastic syndromes.
    King D; Schmidt R; Lesser M; Houk A; Salkeld E; Cogle CR
    Leuk Res; 2020 Sep; 96():106425. PubMed ID: 32702549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.
    Rees S; Williams A
    JBI Libr Syst Rev; 2009; 7(13):492-582. PubMed ID: 27819974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red blood cell transfusion in myelodysplastic syndromes: A systematic review.
    Kaka S; Jahangirnia A; Beauregard N; Davis A; Tinmouth A; Chin-Yee N
    Transfus Med; 2022 Feb; 32(1):3-23. PubMed ID: 34927286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Approaches to Myelodysplastic Syndrome Treatment.
    Bazinet A; Bravo GM
    Curr Treat Options Oncol; 2022 May; 23(5):668-687. PubMed ID: 35320468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The AMBER care bundle for hospital inpatients with uncertain recovery nearing the end of life: the ImproveCare feasibility cluster RCT.
    Koffman J; Yorganci E; Murtagh F; Yi D; Gao W; Barclay S; Pickles A; Higginson I; Johnson H; Wilson R; Bailey S; Ewart C; Evans C
    Health Technol Assess; 2019 Oct; 23(55):1-150. PubMed ID: 31594555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life and physicians' perception in myelodysplastic syndromes.
    Oliva EN; Finelli C; Santini V; Poloni A; Liso V; Cilloni D; Impera S; Terenzi A; Levis A; Cortelezzi A; Ghio R; Musto P; Semenzato G; Clissa C; Lunghi T; Trappolini S; Gaidano V; Salvi F; Reda G; Villani O; Binotto G; Cufari P; Cavalieri E; Spiriti MA
    Am J Blood Res; 2012; 2(2):136-47. PubMed ID: 22762033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Educational and Emotional Needs of Patients with Myelodysplastic Syndromes: An AI Analysis of Multi-Country Social Media.
    Frank PP; Lu MXE; Sasse EC
    Adv Ther; 2023 Jan; 40(1):159-173. PubMed ID: 36136244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using Social Media to Uncover Treatment Experiences and Decisions in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Who Are Ineligible for Intensive Chemotherapy: Patient-Centric Qualitative Data Analysis.
    Booth A; Bell T; Halhol S; Pan S; Welch V; Merinopoulou E; Lambrelli D; Cox A
    J Med Internet Res; 2019 Nov; 21(11):e14285. PubMed ID: 31755871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early lenalidomide treatment for low and intermediate-1 International Prognostic Scoring System risk myelodysplastic syndromes with del(5q) before transfusion dependence.
    Oliva EN; Lauseker M; Aloe Spiriti MA; Poloni A; Cortelezzi A; Palumbo GA; Balleari E; Sanpaolo G; Volpe A; Ricco A; Ronco F; Alati C; D'Errigo MG; Santacaterina I; Kündgen A; Germing U; Latagliata R
    Cancer Med; 2015 Dec; 4(12):1789-97. PubMed ID: 26376955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient and Caregiver Insights into the Disease Burden of Myelodysplastic Syndrome.
    Soper J; Sadek I; Urniasz-Lippel A; Norton D; Ness M; Mesa R
    Patient Relat Outcome Meas; 2022; 13():31-38. PubMed ID: 35153520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematologic complications, healthcare utilization, and costs in commercially insured patients with myelodysplastic syndrome receiving supportive care.
    Powers A; Faria C; Broder MS; Chang E; Cherepanov D
    Am Health Drug Benefits; 2012 Nov; 5(7):455-65. PubMed ID: 24991341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.
    Bokemeyer C; Aapro MS; Courdi A; Foubert J; Link H; Osterborg A; Repetto L; Soubeyran P;
    Eur J Cancer; 2007 Jan; 43(2):258-70. PubMed ID: 17182241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.
    Leaviss J; Davis S; Ren S; Hamilton J; Scope A; Booth A; Sutton A; Parry G; Buszewicz M; Moss-Morris R; White P
    Health Technol Assess; 2020 Sep; 24(46):1-490. PubMed ID: 32975190
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.